Vitali, E.
Palagano, E.
Schiavone, M. L.
Mantovani, G.
Sobacchi, C.
Mazziotti, G.
Lania, A.
Funding for this research was provided by:
Pfizer (ISR 56668477)
Article History
Received: 25 August 2021
Accepted: 3 January 2022
First Online: 12 January 2022
Declarations
:
: All authors declare that there is no conflict of interests in this study.
: Animal procedures were performed in accordance with the ethical rules of the Institutional Animal Care and Use Committee of Humanitas Research Hospital in the framework of the protocol n.876/2017-PR. The murine primary cells generated in this circumstance were used for the present study in accordance with the Reduction guideline (3Rs) which is internationally recognized and encouraged.
: This work has been approved for publication by all authors.